Disturbed Laminar Blood Flow Causes Impaired Fibrinolysis and Endothelial Fibrin Deposition In Vivo
- PMID: 30602198
- DOI: 10.1055/s-0038-1676638
Disturbed Laminar Blood Flow Causes Impaired Fibrinolysis and Endothelial Fibrin Deposition In Vivo
Abstract
Endothelial expression of tissue-type plasminogen activator (t-PA) is crucial for maintaining an adequate endogenous fibrinolysis. It is unknown how endothelial t-PA expression and fibrinolysis are affected by blood flow in vivo. In this study, we investigated the impact of different blood flow profiles on endothelial t-PA expression and fibrinolysis in the arterial vasculature. Induction of disturbed laminar blood flow (D-flow) in the mouse carotid artery potently reduced endothelial t-PA messenger ribonucleic acid and protein expression, and caused fibrin deposition. En face immunohistochemistry demonstrated that arterial areas naturally exposed to D-flow had markedly lower endothelial t-PA levels than areas with sustained laminar blood flow (S-flow), and displayed pronounced fibrin deposition despite an intact endothelium. In t-PA and plasminogen-deficient mice, fibrin deposition did not extend into S-flow areas, indicating that areas of D-flow and S-flow differ, not only in fibrinolytic capacity, but also in coagulation. Furthermore, plasminogen accumulation was found at D-flow areas, and infusion of recombinant t-PA activated fibrinolysis and significantly reduced the fibrin deposits. In conclusion, D-flow potently impairs the fibrinolytic capacity and causes endothelial fibrin deposition in vivo. Our data also indicate that t-PA is the limiting factor for efficient fibrinolysis at the thrombosis-prone D-flow areas in the arterial vasculature.
Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
None declared.
Similar articles
-
Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.J Thromb Haemost. 2016 Dec;14(12):2496-2508. doi: 10.1111/jth.13527. Epub 2016 Nov 23. J Thromb Haemost. 2016. PMID: 27706906
-
Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.J Lab Clin Med. 1991 Dec;118(6):523-30. J Lab Clin Med. 1991. PMID: 1744501
-
Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.Am J Respir Cell Mol Biol. 1999 Dec;21(6):738-45. doi: 10.1165/ajrcmb.21.6.3514. Am J Respir Cell Mol Biol. 1999. PMID: 10572071
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
-
On the role of coagulation and fibrinolysis in atherosclerosis.Ann Epidemiol. 1992 Jul;2(4):427-38. doi: 10.1016/1047-2797(92)90092-5. Ann Epidemiol. 1992. PMID: 1342293 Review.
Cited by
-
Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis.Ann Clin Transl Neurol. 2024 Jan;11(1):30-44. doi: 10.1002/acn3.51930. Epub 2023 Oct 30. Ann Clin Transl Neurol. 2024. PMID: 37902278 Free PMC article.
-
Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives.Int J Mol Sci. 2020 Dec 21;21(24):9760. doi: 10.3390/ijms21249760. Int J Mol Sci. 2020. PMID: 33371312 Free PMC article. Review.
-
Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap).Sci Rep. 2021 Jul 28;11(1):15313. doi: 10.1038/s41598-021-94500-1. Sci Rep. 2021. PMID: 34321516 Free PMC article.
-
The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation.Front Genet. 2020 Nov 9;11:579964. doi: 10.3389/fgene.2020.579964. eCollection 2020. Front Genet. 2020. PMID: 33240326 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous